Financial Advisors Network’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $22.2M | Buy |
175,677
+19,816
| +13% | +$2.61M | 2.72% | 10 |
|
|
2026
Q1 | $21.7M | Sell |
155,861
-40
| -0% | -$5.6K | 3% | 9 |
|
|
2025
Q4 | $19.1M | Buy |
155,901
+34
| +0% | +$4.13K | 2.62% | 9 |
|
|
2025
Q3 | $17.3M | Hold |
155,867
| – | – | 2.45% | 10 |
|
|
2025
Q2 | $17.3M | Sell |
155,867
-149
| -0.1% | -$15.9K | 2.61% | 9 |
|
|
2025
Q1 | $17.5M | Sell |
156,016
-2,309
| -1% | -$238K | 2.9% | 9 |
|
|
2024
Q4 | $14.6M | Buy |
+158,325
| New | +$14.3M | 2.43% | 9 |
|
|
2023
Q4 | $12.8M | Buy |
157,969
+24
| +0% | +$1.87K | 2.58% | 9 |
|
|
2023
Q3 | $11.8M | Buy |
+157,945
| New | +$12.1M | 2.66% | 10 |
|
|
2022
Q4 | $13.4M | Buy |
155,549
+1
| +0% | +$79 | 3.54% | 5 |
|
|
2022
Q3 | $9.6M | Hold |
155,548
| – | – | 2.84% | 9 |
|
|
2022
Q2 | $9.61M | Hold |
155,548
| – | – | 2.69% | 9 |
|
|
2022
Q1 | $9.25M | Sell |
155,548
-12,482
| -7% | -$798K | 2.28% | 10 |
|
|
2021
Q4 | $12.2M | Sell |
168,030
-978
| -0.6% | -$67.4K | 2.74% | 9 |
|
|
2021
Q3 | $11.4M | Sell |
169,008
-173
| -0.1% | -$12.2K | 2.63% | 9 |
|
|
2021
Q2 | $11.7M | Sell |
169,181
-7,881
| -4% | -$526K | 3.44% | 8 |
|
|
2021
Q1 | $11.4M | Buy |
177,062
+9,929
| +6% | +$640K | 3.7% | 7 |
|
|
2020
Q4 | $9.74M | Buy |
167,133
+157
| +0.1% | +$9.47K | 3.35% | 7 |
|
|
2020
Q3 | $10.6M | Sell |
166,976
-112
| -0.1% | -$7.77K | 4.13% | 6 |
|
|
2020
Q2 | $12.9M | Sell |
167,088
-1,169
| -0.7% | -$89.6K | 5.24% | 4 |
|
|
2020
Q1 | $12.6M | Buy |
168,257
+721
| +0.4% | +$49.8K | 6% | 4 |
|
|
2019
Q4 | $10.9M | Buy |
167,536
+14,558
| +10% | +$948K | 4.98% | 4 |
|
|
2019
Q3 | $9.7M | Hold |
152,978
| – | – | 4.96% | 4 |
|
|
2019
Q2 | $9.77M | Sell |
152,978
-14
| -0% | -$921 | 5.25% | 4 |
|
|
2019
Q1 | $9.52M | Sell |
152,992
-1,884
| -1% | -$125K | 5.52% | 4 |
|
|
2018
Q4 | $9.69M | Buy |
+154,876
| New | +$10.8M | 6.03% | 4 |
|
|
2018
Q2 | $10.3M | Buy |
+145,017
| New | +$10.2M | 6.2% | 4 |
|
|
2017
Q4 | $9.12M | Buy |
127,330
+121,161
| +1,964% | +$9.2M | 6.16% | 4 |
|
|
2017
Q3 | $500K | Sell |
6,169
-147
| -2% | -$11.2K | 0.4% | 52 |
|
|
2017
Q2 | $447K | Buy |
6,316
+225
| +4% | +$15K | 0.37% | 50 |
|
|
2017
Q1 | $402K | Buy |
6,091
+1,040
| +21% | +$73.1K | 0.35% | 53 |
|
|
2016
Q4 | $360K | Buy |
+5,051
| New | +$375K | 0.31% | 55 |
|
Other funds holding GILD
Financial Advisors Network's GILD Position: Q2 2026 in Review
Financial Advisors Network increased its Gilead Sciences (GILD) stake by 13% in Q2 2026, buying an estimated $2.61M and bringing the position to 175,677 shares worth $22.2M. The position accounts for 2.72% of the portfolio, ranked #10.
Financial Advisors Network first reported a position in GILD in Q4 2016 and has held it in 32 quarters since. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Financial Advisors Network held 175,677 shares of Gilead Sciences worth $22.2M as of Q2 2026.
- Financial Advisors Network bought 19,816 Gilead Sciences shares in Q2 2026, an estimated $2.61M.
- Gilead Sciences made up 2.72% of Financial Advisors Network's portfolio in Q2 2026, its #10 holding.
- Financial Advisors Network first reported a position in Gilead Sciences in Q4 2016 and has held it in 32 quarters since.
- 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Financial Advisors Network's 13F filing for Q2 2026, filed 14 Aug 2026.